Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Ilkovitch

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Leukocyte Biology|July 15, 2010
Role of immune-regulatory cells in skin pathologyDan Ilkovitch
Blood|February 7, 2009
Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/secDan Ilkovitch, Diana M Lopez
Cancer Immunology, Immunotherapy : CII|January 20, 2004
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chainDan Ilkovitch, Suzanne Ostrand-Rosenberg
Molecular Medicine Reports|August 31, 2016
Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various moleculesDan Ilkovitch, Laura K Ferris
Cancer Research|June 25, 2009
The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppressionDan Ilkovitch, Diana M Lopez
Experimental Dermatology|July 23, 2008
Immune modulation by melanoma-derived factorsDan Ilkovitch, Diana M Lopez
Immunologic Research|November 14, 2013
Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1Dan Ilkovitch, Roberto Carrio, Diana M Lopez
Anticancer Research|October 13, 2012
uPA and uPA-receptor are involved in cancer-associated myeloid-derived suppressor cell accumulationDan Ilkovitch, Roberto Carrio, Diana M Lopez
Journal of Cutaneous Pathology|September 27, 2021
Cutaneous solitary fibrous tumor: Report of three cases with review of histopathological mimicsVladimir Vincek, Penelope Kallis, Ava Vause, et al.
Cancer Research|April 3, 2008
Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cellsDan Ilkovitch, Mary Ellen Handel-Fernandez, Lynn M Herbert, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Leukocyte Biology|July 15, 2010
Role of immune-regulatory cells in skin pathologyDan Ilkovitch
Blood|February 7, 2009
Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/secDan Ilkovitch, Diana M Lopez
Cancer Immunology, Immunotherapy : CII|January 20, 2004
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chainDan Ilkovitch, Suzanne Ostrand-Rosenberg
Molecular Medicine Reports|August 31, 2016
Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various moleculesDan Ilkovitch, Laura K Ferris
Cancer Research|June 25, 2009
The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppressionDan Ilkovitch, Diana M Lopez
Experimental Dermatology|July 23, 2008
Immune modulation by melanoma-derived factorsDan Ilkovitch, Diana M Lopez
Immunologic Research|November 14, 2013
Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1Dan Ilkovitch, Roberto Carrio, Diana M Lopez
Anticancer Research|October 13, 2012
uPA and uPA-receptor are involved in cancer-associated myeloid-derived suppressor cell accumulationDan Ilkovitch, Roberto Carrio, Diana M Lopez
Journal of Cutaneous Pathology|September 27, 2021
Cutaneous solitary fibrous tumor: Report of three cases with review of histopathological mimicsVladimir Vincek, Penelope Kallis, Ava Vause, et al.
Cancer Research|April 3, 2008
Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cellsDan Ilkovitch, Mary Ellen Handel-Fernandez, Lynn M Herbert, et al.
Pageof 2